Biosynex Working Capital to Net Assets Ratio
Biosynex working capital to net assets ratio. Biosynex (ALBIO) has a Working Capital to Net Assets ratio of 81.5% as of June 2025. Working capital of €36.12 Million (current assets of €61.75 Million minus current liabilities of €25.62 Million) is measured against net assets of €44.31 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Biosynex (2008–2024)
Working capital to net assets ratio of Biosynex from 2008 to 2024. This chart shows how Biosynex's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 81.5%, reflecting working capital of €36.12 Million against net assets of €44.31 Million EUR. Explore investment intensity of Biosynex to see how much of total assets are deployed in long-term investments.
Biosynex Working Capital to Net Assets Ratio by Year (2008–2024)
Biosynex working capital to net assets ratio by year from 2008 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Biosynex from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Biosynex balance sheet assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -26.8% | €-21.59 Million | €80.50 Million | €64.39 Million | €85.98 Million | ▼ -67.5 pp |
| 2023 | 40.6% | €50.53 Million | €124.31 Million | €91.35 Million | €40.82 Million | ▼ -31.2 pp |
| 2022 | 71.8% | €119.75 Million | €166.76 Million | €159.24 Million | €39.50 Million | ▼ -15.1 pp |
| 2021 | 86.9% | €145.87 Million | €167.81 Million | €198.78 Million | €52.91 Million | ▲ +24.2 pp |
| 2020 | 62.7% | €41.57 Million | €66.29 Million | €87.53 Million | €45.96 Million | ▲ +40.5 pp |
| 2019 | 22.2% | €6.75 Million | €30.38 Million | €15.11 Million | €8.36 Million | ▼ -2.3 pp |
| 2018 | 24.5% | €7.17 Million | €29.26 Million | €12.41 Million | €5.25 Million | ▼ -3.0 pp |
| 2017 | 27.5% | €7.95 Million | €28.91 Million | €13.71 Million | €5.76 Million | ▲ +10.9 pp |
| 2016 | 16.7% | €4.06 Million | €24.36 Million | €13.37 Million | €9.31 Million | ▲ +6.7 pp |
| 2015 | 10.0% | €2.11 Million | €21.13 Million | €5.73 Million | €3.63 Million | ▼ -43.9 pp |
| 2014 | 53.9% | €1.86 Million | €3.45 Million | €3.58 Million | €1.72 Million | ▲ +0.1 pp |
| 2013 | 53.8% | €2.13 Million | €3.96 Million | €3.84 Million | €1.71 Million | ▼ -3.4 pp |
| 2012 | 57.2% | €2.96 Million | €5.18 Million | €4.50 Million | €1.53 Million | ▼ -35.9 pp |
| 2011 | 93.1% | €4.81 Million | €5.16 Million | €5.17 Million | €365.46K | ▼ -54.6 pp |
| 2010 | 147.8% | €184.09K | €124.59K | €687.61K | €503.52K | ▲ +125.7 pp |
| 2009 | 22.1% | €-75.50K | €-341.55K | €401.40K | €476.90K | ▲ +49.2 pp |
| 2008 | -27.1% | €41.63K | €-153.74K | €396.02K | €354.39K | — |